Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Primary Immunogenicity Objective • To describe the immune response, relative to baseline status, following receipt of Bexsero as measured by hSBA performed with a panel of MnB test strains assessed 1 month after the second vaccination with Bexsero vaccine. Primary Safety Objective • To describe local reactions and systemic events following receipt of Bexsero vaccine.
Inclusion criteria
- Test the safety and immunogenicity of Bexsero used as a vaccine for Neisseria meningitidis